A 15 year old adolescent girl with homozygous sickle cell disease presented with a six month history of progressive shortness of breath, dyspnea on exertion, and chest pain. Her past history was significant for a prior thrombotic cerebrovascular accident treated with long term transfusion therapy, two prior episodes of pulmonary emboli treated with chronic anticoagulation (2 and 5 years prior to presentation), and a prior diagnosis of pulmonary hypertension. The initial baseline pulmonary hypertension evaluation prior to treatment and 2 years prior to presentation included a right heart catheterization with a right atrial pressure (RAP) of 8 mmHg, mean pulmonary artery pressure (PAP) of 43 mmHg (normal <25), cardiac index (CI) of 3.08 L/min./m2 (normal >2.50), pulmonary vascular resistance (PVR) 902 dynes/sec./cm5, and a mixed venous oxygen saturation (SvO2) of 65%. In addition, a pulmonary angiogram seven months prior to referral showed normal perfusion of the central pulmonary arteries, but filling defects were noted in the third and fourth order PA branches of the left lower lobe, the lateral aspect of the right middle lobe, and the lateral aspect of the right upper lobe. A surgical evaluation at that time concluded that these peripheral lesions were inoperable. Despite treatment with supplemental oxygen, hydroxyurea, intensified transfusion therapy, sildenafil, and bosentan, her clinical symptoms progressed over the six months prior to referral. The CBC showed a hemoglobin of 10.5 grams/dL with the majority of erythrocytes representing transfused red cells from her chronic transfusion therapy. Her peripheral blood smear (Image 1) demonstrated anisocytosis, occasional Howell-Jolly bodies (arrow in Image 1), and occasional sickle cells, consistent with her sickle cell anemia and history of transfusion. Further evaluation included a transthoracic Doppler echocardiogram, six minute walk test, a pulmonary ventilation perfusion (VQ) scan, CT angiogram, and right heart catheterization. Color flow Doppler from the echocardiogram (Image 2) showed severe dilation of the right atrium and right ventricle with flattening and bowing of the intraventricular septum into the left ventricle. Normally, the right atrium and right ventricle should be smaller than the corresponding structures on the left during systole. Severe tricuspid regurgitation is also seen (blue flow in Image 2), and the peak Doppler tricuspid regurgitant jet velocity (TRV) was 4.5 meters per second (Image 3). A six minute walk test distance was 120 meters (normal > 500 meters). The VQ scan was intermediate to high probability for a pulmonary embolism with normal ventilation (image 4), a major perfusion defect in the lateral basal segment of the left lower lobe (arrow in image 5), and partial perfusion segmental defects in the left upper lobe, the lingula, and the right upper lobe (image 5) consistent with the findings of the prior pulmonary angiogram. A CT angiogram was performed to further evaluate chronic thromboembolic pulmonary hypertension as a cause of severe pulmonary hypertension. The study was negative for a persistent large vessel thrombus, but did demonstrate severe dilation of the main and the right and left branch pulmonary arteries (Image 6). Normally, the main pulmonary artery has an equal or smaller diameter than the ascending or descending aorta. A right heart catheterization demonstrated a RAP of 8 mmHg, mean PAP of 50 mmHg, cardiac index of 4.04 L/min./m2, PVR 498 dynes/sec./cm5, and SvO2 68% at baseline with no mean PAP decrease in response to either inhaled nitric oxide or sildenafil in the catheterization laboratory. The diagnostic impression was severe progressive pulmonary hypertension secondary to sickle cell disease and inoperable, presumed chronic small vessel pulmonary emboli. She initiated continuous intravenous Epoprostenol therapy, and was discharged to home once she was tolerating an appropriate dose.
. Author manuscript; available in PMC: 2012 Nov 19.
Published in final edited form as: Am J Hematol. 2008 Jan;83(1):71–72. doi: 10.1002/ajh.21039
Severe Pulmonary Hypertension in an Adolescent with Sickle Cell Disease
James G Taylor VI
1, Gerald M Woods
2, Roberto Machado
1, Gregory J Kato
1, Mark T Gladwin
1
James G Taylor VI, M.D.
1Vascular Medicine Branch, NHLBI, National Institutes of Health, Bethesda, MD
Find articles by James G Taylor VI
Gerald M Woods, M.D.
2Division of Hematology/Oncology, Children's Mercy Hospital, Kansas City, MO
Find articles by Gerald M Woods
Roberto Machado, M.D.
1Vascular Medicine Branch, NHLBI, National Institutes of Health, Bethesda, MD
Find articles by Roberto Machado
Gregory J Kato, M.D.
1Vascular Medicine Branch, NHLBI, National Institutes of Health, Bethesda, MD
Find articles by Gregory J Kato
Mark T Gladwin, M.D.
1Vascular Medicine Branch, NHLBI, National Institutes of Health, Bethesda, MD
Find articles by Mark T Gladwin
1Vascular Medicine Branch, NHLBI, National Institutes of Health, Bethesda, MD
2Division of Hematology/Oncology, Children's Mercy Hospital, Kansas City, MO
✉
Correspondence: James G. Taylor VI, M.D. Vascular Medicine Branch, NHLBI, NIH Building 10-CRC, Room 5-5140 10 Center Drive MSC-1476 Bethesda, MD 20892-1476 Phone (301)-435-7895 Fax (301)-451-7091 jamesta@mail.nih.gov
PMCID: PMC3501196 NIHMSID: NIHMS30320 PMID: 17726682
The publisher's version of this article is available at Am J Hematol